M Dustin Boone1, Leo A Celi2, Ben G Ho3, Michael Pencina4, Michael P Curry5, Yotam Lior6, Daniel Talmor7, Victor Novack8. 1. Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. Electronic address: mboone@bidmc.harvard.edu. 2. Department of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA; Harvard-Massachusetts Institute of Technology Division of Health Science Technology, Cambridge, MA. 3. Harvard-Massachusetts Institute of Technology Division of Health Science Technology, Cambridge, MA. 4. Department of Biostatistics, School of Public Health, Boston University, Boston, MA. 5. Department of Medicine, Division of Hepatology, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA. 6. Clinical Research Center, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel. 7. Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. 8. Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Clinical Research Center, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Abstract
PURPOSE: Cirrhosis is a common condition that complicates the management of patients who require critical care. There is interest in identifying scoring systems that may be used to predict outcome because of the poor odds for recovery despite high-intensity care. We sought to evaluate how Model for End-Stage Liver Disease (MELD), an organ-specific scoring system, compares with other severity of illness scoring systems in predicting short- and long-term mortality for critically ill cirrhotic patients. MATERIALS AND METHODS: This was a retrospective cohort study involving seven intensive care units (ICUs) in a tertiary care, academic medical center. Adult patients with cirrhosis who were admitted to an ICU between 2001 and 2008 were evaluated. Severity of illness scores (MELD and Sequential Organ Failure Assessment [SOFA]) were calculated on admission and at 24 and 48 hours. The primary end points were 28-day and 1-year all-cause mortality. RESULTS: Of 19742 ICU hospitalizations, 848 had cirrhosis. Relevant data were available for 521 patients (73%). Of these cases, 353 patients (69.5%) were admitted to medical ICU (MICU), and the other 155 (30.5%), to surgical unit. Alcohol abuse and hepatitis C were the most common reasons for cirrhosis. Patients who died within 28 days were more likely to receive mechanical ventilation, pressors, and renal replacement therapy. Among 353 medical admissions, both MELD and SOFA were found to be significantly associated with both 28-day and 1-year mortality. Among the 155 surgical admissions, both scores were found to be not significant for 28-day mortality but were significant for 1 year. CONCLUSIONS: Our results demonstrate that the prognostic ability of a variety of scoring systems strongly depends on the patient population. In the MICU population, each model (MELD + SOFA, MELD, and SOFA) demonstrates excellent discrimination for 28-day and 1-year mortality. However, these scoring systems did not predict 28-day mortality in the surgical ICU group but were significant for 1-year mortality. This suggests that patients admitted to a surgical ICU will behave similarly to their MICU cohort if they survive the perioperative period.
PURPOSE:Cirrhosis is a common condition that complicates the management of patients who require critical care. There is interest in identifying scoring systems that may be used to predict outcome because of the poor odds for recovery despite high-intensity care. We sought to evaluate how Model for End-Stage Liver Disease (MELD), an organ-specific scoring system, compares with other severity of illness scoring systems in predicting short- and long-term mortality for critically ill cirrhoticpatients. MATERIALS AND METHODS: This was a retrospective cohort study involving seven intensive care units (ICUs) in a tertiary care, academic medical center. Adult patients with cirrhosis who were admitted to an ICU between 2001 and 2008 were evaluated. Severity of illness scores (MELD and Sequential Organ Failure Assessment [SOFA]) were calculated on admission and at 24 and 48 hours. The primary end points were 28-day and 1-year all-cause mortality. RESULTS: Of 19742 ICU hospitalizations, 848 had cirrhosis. Relevant data were available for 521 patients (73%). Of these cases, 353 patients (69.5%) were admitted to medical ICU (MICU), and the other 155 (30.5%), to surgical unit. Alcoholabuse and hepatitis C were the most common reasons for cirrhosis. Patients who died within 28 days were more likely to receive mechanical ventilation, pressors, and renal replacement therapy. Among 353 medical admissions, both MELD and SOFA were found to be significantly associated with both 28-day and 1-year mortality. Among the 155 surgical admissions, both scores were found to be not significant for 28-day mortality but were significant for 1 year. CONCLUSIONS: Our results demonstrate that the prognostic ability of a variety of scoring systems strongly depends on the patient population. In the MICU population, each model (MELD + SOFA, MELD, and SOFA) demonstrates excellent discrimination for 28-day and 1-year mortality. However, these scoring systems did not predict 28-day mortality in the surgical ICU group but were significant for 1-year mortality. This suggests that patients admitted to a surgical ICU will behave similarly to their MICU cohort if they survive the perioperative period.
Authors: Rodrigo Cavallazzi; Olatilewa O Awe; Tajender S Vasu; Amyn Hirani; Urvashi Vaid; Benjamin E Leiby; Walter K Kraft; Gregory C Kane Journal: J Crit Care Date: 2012-01-09 Impact factor: 3.425
Authors: Michael J Pencina; Ralph B D'Agostino; Karol M Pencina; A Cecile J W Janssens; Philip Greenland Journal: Am J Epidemiol Date: 2012-08-08 Impact factor: 4.897
Authors: E Cholongitas; M Senzolo; D Patch; K Kwong; V Nikolopoulou; G Leandro; S Shaw; A K Burroughs Journal: Aliment Pharmacol Ther Date: 2006-04-01 Impact factor: 8.171
Authors: Swee H Teh; David M Nagorney; Susanna R Stevens; Kenneth P Offord; Terry M Therneau; David J Plevak; Jayant A Talwalkar; W Ray Kim; Patrick S Kamath Journal: Gastroenterology Date: 2007-01-25 Impact factor: 22.682
Authors: Vincent Das; Pierre-Yves Boelle; Arnaud Galbois; Bertrand Guidet; Eric Maury; Nicolas Carbonell; Richard Moreau; Georges Offenstadt Journal: Crit Care Med Date: 2010-11 Impact factor: 7.598
Authors: Eun L Langman; Paul V Suhocki; Herbert I Hurwitz; Michael A Morse; Rebecca A Burbridge; Tony P Smith; Charles Y Kim Journal: J Gastrointest Oncol Date: 2016-12
Authors: Christin Edmark; Mark J W McPhail; Max Bell; Tony Whitehouse; Julia Wendon; Kenneth B Christopher Journal: Intensive Care Med Date: 2016-01-28 Impact factor: 17.440
Authors: Gabriel Dumitrescu; Anna Januszkiewicz; Anna Ågren; Maria Magnusson; Staffan Wahlin; Jan Wernerman Journal: Medicine (Baltimore) Date: 2017-06 Impact factor: 1.889
Authors: Alejandro Álvaro-Meca; María A Jiménez-Sousa; Alexandre Boyer; José Medrano; Holger Reulen; Thomas Kneib; Salvador Resino Journal: BMC Infect Dis Date: 2016-03-12 Impact factor: 3.090